Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • FloodlightGenomics
    Registered Vendor
    • Nov 2015
    • 1

    #1

    High capacity, low cost, targeted NGS

    Hello SEQanswers
    My name is Kurt Lamour and I run a company (Floodlight Genomics) that provides a new low cost option for targeted genetic sequencing (MonsterPlex). MonsterPlex is a single-tube PCR-based technology to amplify 10's to 100's of targets from small amounts DNA (e.g. 20-40ng). Custom indices are added during the multiplex PCR and we currently index up to 6000 samples for pooling (loaded as a single library) on an Illumina or Ion device.

    Total target sizes can be either 80, 380 or 480bp. It depends on your goals and/or the sequencing device and configuration you'd like to use.

    I'm an academic research scientist (molecular epidemiologist) who developed MonsterPlex to better use the huge amount of excess sequence data our lab was producing using WGS and GBS. Thus far we've worked directly with academic research scientists on native grasses, insects, infected plants and large mammals. Any target is fair game!

    Best I can tell, our project costs are low. For example, the cost to analyze 1000 samples for 100 targets (=100,000 data points) is less than $0.10/target at >20X coverage per target. You provide the DNA and the target sequences and we deliver the sample-specific sequence data. MonsterPlex should work equally well on cDNA, making for some interesting RNAseq options - although I've yet to try it.

    Check us out at:

    Floodlightgenomics.com

    Or send me a message if you have questions.
  • james hadfield
    Moderator
    Cambridge, UK
    Community Forum
    • Feb 2008
    • 224

    #2
    Hi Kurt,
    Please get in touch directly. [email protected], @CIgenomics, or http://core-genomics.blogspot.co.uk.
    I'd like to find out more and will take a look.
    James.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Working...